mannitol has been researched along with Skin Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Balan, S; Bhardwaj, N; Blazquez, AB; Gimenez, G; Gnjatic, S; Holman, RM; Lattanzi, M; Mandeli, J; Marron, TU; McClain, CB; Meseck, M; Ott, PA; Pavlick, A; Sabado, RL; Salazar, AM | 1 |
| Koeppel, AF; Kumar, P; Lynch, KT; Mauldin, IS; Melssen, MM; Meneveau, MO; Pollack, KE; Slingluff, CL; Sol-Church, K; Turner, S; Young, SJ | 1 |
| Andrade Filho, PA; Donnenberg, A; Fourcade, J; Janjic, B; Kirkwood, JM; Krieg, A; Kudela, P; Land, SR; Sander, C; Shen, H; Zarour, HM | 1 |
| McGuire, S; Yuan, F | 1 |
| Barnd, DL; Chianese-Bullock, KA; Deacon, DH; Eastham, S; Engelhard, VH; Galavotti, H; Gibson, J; Grosh, WW; Hibbitts, S; Merrill, P; Neese, PY; Patterson, JW; Petroni, GR; Ross, M; Slingluff, CL; Teates, D; Wiernasz, CJ; Woodson, EM; Yamshchikov, GV | 1 |
| Collins, S; Coventry, B; Farrelly, M; Hersey, P; Hirst, D; Johnson, H; Menzies, SW; Nguyen, T | 1 |
| Allred, JB; Celis, E; Creagan, ET; Ingle, JN; Kaur, JS; Loprinzi, CL; Markovic, SN; Nevala, WK; Pitot, HC; Pittelkow, MR; Rao, RD; Suman, VJ | 1 |
| Celis, E | 1 |
| Kishimoto, S; Nagata, M; Noda, Y; Shibagaki, R; Takenaka, H; Yasuno, H | 1 |
| Thumb, N | 1 |
| Kalmus, J; Okunieff, P; Vaupel, P | 1 |
| Colburn, NH; Gindhart, TD; Nakamura, Y | 1 |
6 trial(s) available for mannitol and Skin Neoplasms
| Article | Year |
|---|---|
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.
Topics: Adjuvants, Immunologic; Aged; Antigens, Neoplasm; Cancer Vaccines; Carboxymethylcellulose Sodium; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cross-Priming; Female; Humans; Immunity, Cellular; Immunity, Humoral; Interferon Inducers; Male; Mannitol; Melanoma; Membrane Proteins; Middle Aged; Oleic Acids; Patient Safety; Poly I-C; Polylysine; Skin Neoplasms; Treatment Outcome | 2020 |
Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients.
Topics: Aged; Aged, 80 and over; Cancer Vaccines; CD8-Positive T-Lymphocytes; Female; Humans; Immunization; Male; Mannitol; Melanoma; Middle Aged; Neoplasm Proteins; Oleic Acids; Oligodeoxyribonucleotides; Peptide Fragments; Pilot Projects; Skin Neoplasms; T-Lymphocytes, Cytotoxic | 2008 |
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
Topics: Adult; Aged; Cancer Vaccines; Dendritic Cells; Drug Administration Schedule; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-2; Lymph Nodes; Male; Mannitol; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Peptide Fragments; Radiography; Skin Neoplasms; Survival Analysis; T-Lymphocytes; Thoracic Neoplasms; Treatment Outcome | 2003 |
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cytokines; Enzyme-Linked Immunosorbent Assay; Epitopes; Epitopes, T-Lymphocyte; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Inflammation; Interferon-gamma; Lymphocytes; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Peptides; Skin Neoplasms; Time Factors; Treatment Outcome | 2005 |
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cancer Vaccines; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-A2 Antigen; Humans; Hypersensitivity, Delayed; Immunophenotyping; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Vaccines, Subunit | 2006 |
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction.
Topics: Adult; Aged; Amino Acid Sequence; Cancer Vaccines; Dendritic Cells; Epitopes; Female; Freund's Adjuvant; Granulocyte-Macrophage Colony-Stimulating Factor; HLA Antigens; Humans; Lymphocyte Activation; Male; Mannitol; Melanoma; Middle Aged; Neoplasm Staging; Oleic Acids; Oligopeptides; Skin Neoplasms; Survival Analysis; Survival Rate; T-Lymphocytes, Cytotoxic; Treatment Outcome | 2007 |
6 other study(ies) available for mannitol and Skin Neoplasms
| Article | Year |
|---|---|
Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Arginase; Biopsy; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD40 Ligand; Clinical Trials, Phase I as Topic; Female; Freund's Adjuvant; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Injections, Intralesional; Lipids; Male; Mannitol; Melanoma; Middle Aged; Oleic Acids; Randomized Controlled Trials as Topic; Signal Transduction; Skin; Skin Neoplasms; Th1 Cells; Toll-Like Receptors; Tumor Microenvironment; Vaccination; Vaccines, Subunit; Young Adult | 2020 |
Improving interstitial transport of macromolecules through reduction in cell volume fraction in tumor tissues.
Topics: Animals; Biological Transport; Cell Size; Cytotoxins; Dextrans; Drug Delivery Systems; Ethacrynic Acid; Extracellular Fluid; Fibrosarcoma; Mannitol; Rats; Skin Neoplasms | 2012 |
Recurrent malignant proliferating trichilemmal tumour: local management with ethanol injection.
Topics: Anemia; Anti-Bacterial Agents; Antineoplastic Agents; Diuretics, Osmotic; Ethanol; Female; Hair Follicle; Hemostasis; Humans; Iron; Mannitol; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Scalp; Skin Neoplasms | 1998 |
[Side effects in immunosuppressive therapy].
Topics: Alopecia; Amenorrhea; Anemia; Azathioprine; Bacterial Infections; Chlorambucil; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Mannitol; Mycoses; Procarbazine; Skin Neoplasms; Spermatogenesis; Virus Diseases | 1975 |
Effect of intraperitoneal versus intravenous glucose administration on laser Doppler flow in murine FSaII tumors and normal skin.
Topics: Animals; Galactose; Glucose Solution, Hypertonic; Hypertonic Solutions; Injections, Intraperitoneal; Injections, Intravenous; Lasers; Mannitol; Mice; Mice, Inbred C3H; Regional Blood Flow; Skin; Skin Neoplasms; Ultrasonics | 1989 |
Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA.
Topics: Animals; Antioxidants; Arachidonic Acid; Arachidonic Acids; Cell Line; Cell Transformation, Neoplastic; Cocarcinogenesis; Hydroxides; Hydroxyl Radical; Lipoxygenase Inhibitors; Mannitol; Mice; Phorbols; Skin Neoplasms; Superoxide Dismutase; Superoxides; Tetradecanoylphorbol Acetate | 1985 |